I just had a re-read of the latest PD1-Vaxx announcement. Below is an excerpt:
After 6 weeks (day 43) treatment with PD1-Vaxx, one patient’s tumor was non-measurable indicating a complete response (CR), with three patients showing stabilization of disease (SD) and a single patient progressing (PD). The status of two patients from cohort 1 (1 x SD, 1 x CR) were unchanged 2 IMUGENE LIMITED ACN 009 179 551 at day 85. These are encouraging results in patients who have progressed after previous treatment with checkpoint inhibitors including Keytruda®, Opdivo® or Tecentriq®. Further results and scans are scheduled over the coming weeks.
I actually missed the bold italic bit as I was busy when the announcement was released so had skim read it. I did not realise the patients had no success with the likes of Keytruda, Opdivo and Tecentriq! If the results is confirmed over the scheduled scans and replicated in Phase II, I dare say the likes of BeiGene might actually come knocking! That is if they truly want to knock Keytruda and Opdivo off their perch.
- Forums
- ASX - By Stock
- Media Thread
I just had a re-read of the latest PD1-Vaxx announcement. Below...
-
- There are more pages in this discussion • 14,676 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.1¢ |
Change
-0.002(3.77%) |
Mkt cap ! $379.2M |
Open | High | Low | Value | Volume |
5.3¢ | 5.3¢ | 5.1¢ | $1.015M | 19.58M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
54 | 7835902 | 5.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.2¢ | 11705865 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
53 | 6855510 | 0.051 |
96 | 6675097 | 0.050 |
24 | 3870500 | 0.049 |
18 | 1325211 | 0.048 |
5 | 417000 | 0.047 |
Price($) | Vol. | No. |
---|---|---|
0.052 | 11705865 | 9 |
0.053 | 1323676 | 9 |
0.054 | 599025 | 4 |
0.055 | 2013608 | 13 |
0.056 | 790463 | 9 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
NEWS
Exceptional lithium assays uncovered at Falcon Lake – expanding mineralisation, big potential ahead
NEWS
Biotech innovator secures $5.5M R&D tax incentive refund – major boost for cutting-edge programs
IMU (ASX) Chart |